Enhanced Diabetic Wound Healing Using Electrospun Biocompatible PLGA-Based Saxagliptin Fibrous Membranes
Overview
Affiliations
Delayed diabetic wound healing is an adverse event that frequently leads to limb disability or loss. A novel and promising vehicle for the treatment of diabetic wounds is required for clinical purposes. The biocompatible and resorbable poly (lactic-co-glycolic acid) (PLGA)-based fibrous membranes prepared by electrospinning that provide a sustained discharge of saxagliptin for diabetic wound healing were fabricated. The concentration of released saxagliptin in Dulbecco’s phosphate-buffered saline was analyzed for 30 days using high-performance liquid chromatography. The effectiveness of the eluted saxagliptin was identified using an endothelial progenitor cell migration assay in vitro and a diabetic wound healing in vivo. Greater hydrophilicity and water storage were shown in the saxagliptin-incorporated PLGA membranes than in the pristine PLGA membranes (both p < 0.001). For diabetic wound healing, the saxagliptin membranes accelerated the wound closure rate, the dermal thickness, and the heme oxygenase-1 level over the follicle areas compared to those in the pristine PLGA group at two weeks post-treatment. The saxagliptin group also had remarkably higher expressions of insulin-like growth factor I expression and transforming growth factor-β1 than the control group (p = 0.009 and p < 0.001, respectively) in diabetic wounds after treatment. The electrospun PLGA-based saxagliptin membranes exhibited excellent biomechanical and biological features that enhanced diabetic wound closure and increased the antioxidant activity, cellular granulation, and functionality.
Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications.
Benitez-Camacho J, Ballesteros A, Beltran-Camacho L, Rojas-Torres M, Rosal-Vela A, Jimenez-Palomares M Stem Cell Res Ther. 2023; 14(1):324.
PMID: 37950274 PMC: 10636846. DOI: 10.1186/s13287-023-03537-8.
Stretchable Sensors: Novel Human Motion Monitoring Wearables.
Cho C, Chung P, Tsai Y, Yang Y, Lin S, Huang P Nanomaterials (Basel). 2023; 13(16).
PMID: 37630960 PMC: 10459719. DOI: 10.3390/nano13162375.
Electrospun Fibrous Silica for Bone Tissue Engineering Applications.
Stoica Oprea A, Birca A, Gherasim O, Ficai A, Grumezescu A, Oprea O Pharmaceutics. 2023; 15(6).
PMID: 37376176 PMC: 10304373. DOI: 10.3390/pharmaceutics15061728.
Balachandran A, Siyumbwa S, Froemming G, Beata M, Malgorzata J, Lavilla Jr C Life (Basel). 2023; 13(6).
PMID: 37374190 PMC: 10304334. DOI: 10.3390/life13061409.
Nanofibrous insulin/vildagliptin core-shell PLGA scaffold promotes diabetic wound healing.
Lee C, Chen D, Hsieh M, Hung K, Huang S, Cho C Front Bioeng Biotechnol. 2023; 11:1075720.
PMID: 37168611 PMC: 10164987. DOI: 10.3389/fbioe.2023.1075720.